← Leaderboards
Fuyuhiko Tamanoi
University Of California Los Angeles
$5,574,151
Attributed
$7,142,432
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $898K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,142,432 · 5
By mechanism
R01$6,648,198 · 2
P30$484,234 · 1
R13$10,000 · 1
P01$0 · 1
Top collaborators
- Andre Elias Nel8 shared
- James Fraser Stoddart8 shared
- Jeffrey I Zink8 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Loren Gi Fong$14,142,294
- Jeffrey I Zink$4,550,823
- Andre Elias Nel$21,296,649
- James Fraser Stoddart$522,761
- Danny Elias Hadaya$78,340
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseInvestigationTumorPharmaceutical PreparationsAntineoplastic AgentsInstitutesMutantDrug Delivery SystemsResearch PersonnelPlaySignal TransductionGrantLaboratoriesPublic Health RelevanceDesignResearch StudyFundingSignal PathwayProteinsCellsCell LineCancer CellCancer TherapyPathway Interactions
Grant awards (30)
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$380,516
R01 · FY2014 · CA · contact PI
Activating mutants of mTOR$327,750
R01 · FY2014 · CA · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$22,823
R01 · FY2014 · CA · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$369,346
R01 · FY2013 · CA · contact PI
Activating mutants of mTOR$317,614
R01 · FY2013 · CA · contact PI
Signal Transduction and Therapeutics$146,441
P30 · FY2013 · CA · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$64,637
R01 · FY2013 · CA · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$393,575
R01 · FY2012 · CA · contact PI
Activating mutants of mTOR$337,887
R01 · FY2012 · CA · contact PI
Signal Transduction and Therapeutics$110,840
P30 · FY2012 · CA · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$45,234
R01 · FY2012 · CA · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$394,252
R01 · FY2011 · CA · contact PI
Activating mutants of mTOR$337,887
R01 · FY2011 · CA · contact PI
Signal Transduction and Therapeutics$66,553
P30 · FY2011 · CA · contact PI
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs$420,659
R01 · FY2010 · CA · contact PI
Activating mutants of mTOR$348,337
R01 · FY2010 · CA · contact PI
Signal Transduction and Therapeutics$82,380
P30 · FY2010 · CA · contact PI
Rheb, a highly conserved farnesylated G-protein$106,858
R01 · FY2009 · CA · contact PI
Signal Transduction and Therapeutics$78,020
P30 · FY2009 · CA · contact PI
Rheb, a highly conserved farnesylated G-protein$338,645
R01 · FY2007 · CA · contact PI
Rheb, a highly conserved farnesylated G-protein$348,759
R01 · FY2006 · CA · contact PI
Rheb, a highly conserved farnesylated G-protein$357,152
R01 · FY2005 · CA
Rheb, a highly conserved farnesylated G-protein$355,284
R01 · FY2004 · CA
Rheb, a highly conserved farnesylated G-protein$353,043
R01 · FY2003 · CA
ISOPRENYLATION OF RAS AND OTHER PROTEINS IN YEAST$56,080
R01 · FY2003 · CA
ISOPRENYLATION OF RAS AND OTHER PROTEINS IN YEAST$333,540
R01 · FY2002 · CA
FASEB Summer Conference, July 20-25, 2002$10,000
R13 · FY2002 · CA
FARNESYLTRANSFERAE INHIBITOR ON PROSTATE AND BREAST CANCER$0
P01 · FY2002 · CA
ISOPRENYLATION OF RAS AND OTHER PROTEINS IN YEAST$323,826
R01 · FY2001 · CA
ISOPRENYLATION OF RAS AND OTHER PROTEINS IN YEAST$314,494
R01 · FY2000 · CA